Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

MORPHINE SULFATE

MORPHINE SULFATE

Standard Dose
8MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MORPHINE SULFATE is listed in Drugs@FDA under application 211452 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MORPHINE SULFATE Form and strength INJECTABLE;INJECTION - 8MG/ML Sponsor HIKMA Submission history Latest submission status date: 2023-01-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview MORPHINE SULFATE is listed in Drugs@FDA under application 211452 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MORPHINE SULFATE Form and strength INJECTABLE;INJECTION - 8MG/ML Sponsor HIKMA Submission history Latest submission status date: 2023-01-12 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.